Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–330.
CAS
PubMed
PubMed Central
Google Scholar
Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate. 2002;53:263–76.
Article
CAS
PubMed
Google Scholar
Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate. 2008;68:306–20.
Article
CAS
PubMed
Google Scholar
Chen Y, Wei J. Identification of pathogen signatures in prostate Cancer using RNA-seq. PLoS One. 2015;10:e0128955.
Article
PubMed
PubMed Central
CAS
Google Scholar
Le Tortorec A, Matusali G, Mahé D, Aubry F, Mazaud-Guittot S, Houzet L, et al. From ancient to emerging infections: the odyssey of viruses in the male genital tract. Physiol Rev. https://doi.org/10.1152/physrev.00021.2020 [Epub ahead of print].
Yang L, Xie S, Feng X, Chen Y, Zheng T, Dai M, et al. Worldwide prevalence of human papillomavirus and relative risk of prostate Cancer: a meta-analysis. Sci Rep. 2015;5:14667.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yin B, Liu W, Yu P, Liu C, Chen Y, Duan X, et al. Association between human papillomavirus and prostate cancer: a meta-analysis. Oncol Lett. 2017;14:1855–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Russo GI, Calogero AE, Condorelli RA, Scalia G, Morgia G, La Vignera S. Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis. Aging Male. 2018;23:1–7.
Google Scholar
Moghoofei M, Keshavarz M, Ghorbani S, Babaei F, Nahand JS, Tavakoli A, et al. Association between human papillomavirus infection and prostate cancer: a global systematic review and meta-analysis. Asia Pac J Clin Oncol. 2019;15:e59–67.
Article
PubMed
Google Scholar
McNicol PJ, Dodd JG. High prevalence of human papillomavirus in prostate tissues. Urol J. 1991;145:850–3.
Article
CAS
Google Scholar
Arias M, Fan H. The saga of XMRV: a virus that infects human cells but is not a human virus. Emerg Microbes Infect. 2014;3(4):e.
PubMed
PubMed Central
Google Scholar
Chen AC, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D, et al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res. 2011;17:613–7.
Article
CAS
PubMed
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6:e1000097.
Article
PubMed
PubMed Central
Google Scholar
Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res. 1992;52:5991–6.
CAS
PubMed
Google Scholar
Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, et al. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol. 1992;148:1822–6.
Article
CAS
PubMed
Google Scholar
Rotola A, Monini P, Di Luca D, Savioli A, Simone R, Secchiero P, et al. Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer. 1992;52:359–65.
Article
CAS
PubMed
Google Scholar
Dodd JG, Paraskevas M, McNicol PJ. Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol. 1993;149:400–2.
Article
CAS
PubMed
Google Scholar
Tu H, Jacobs SC, Mergner WJ, Kyprianou N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology. 1994;44:726–31.
Article
CAS
PubMed
Google Scholar
Moyret-Lalle C, Marçais C, Jacquemier J, Moles JP, Daver A, Soret JY, et al. Ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer. 1995;64:124–9.
Article
CAS
PubMed
Google Scholar
Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, et al. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate. 1996;28:117–23.
Article
CAS
PubMed
Google Scholar
Terris MK, Peehl DM. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology. 1997;50:150–6.
Article
CAS
PubMed
Google Scholar
Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res. 1999;59:823–5.
CAS
PubMed
Google Scholar
Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, et al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers. 2004;19:257–61.
Article
CAS
PubMed
Google Scholar
Leiros GJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Epidemiol Health. 2015;37:e2015005.
Article
Google Scholar
Silvestre RV, Leal MF, Demachki S, Nahum MC, Bernardes JG, Rabenhorst SH, et al. Low frequency of human papillomavirus detection in prostate tissue from individuals from northern Brazil. Mem Inst Oswaldo Cruz. 2009;104:665–7.
Article
PubMed
Google Scholar
Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer. 2010;10:326.
Article
PubMed
PubMed Central
CAS
Google Scholar
Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A, et al. The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis. 2011;43:64–9.
Article
PubMed
Google Scholar
Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V, et al. HPV persistence and its oncogenic role in prostate tumors. J Med Virol. 2012;84:1636–45.
Article
CAS
PubMed
Google Scholar
Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS. Human papillomavirus and Epstein Barr virus in prostate Cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate Cancer. Prostate. 2013;73:236–41.
Article
CAS
PubMed
Google Scholar
Ghasemian E, Monavari SH, Irajian GR, Jalali Nodoshan MR, Roudsari RV, Yahyapour Y. Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran. Asian Pac J Cancer Prev. 2013;14:3305–8.
Article
PubMed
Google Scholar
Mokhtari M, Taghizadeh F, Hani M. Is prostatic adenocarcinoma in a relationship with human papilloma virus in Isfahan -Iran. J Res Med Sci. 2013;18:707–10.
PubMed
PubMed Central
Google Scholar
Michopoulou V, Derdas SP, Symvoulakis E, Mourmouras N, Nomikos A, Delakas D, et al. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. Tumour Biol. 2014;35:12765–73.
Article
CAS
PubMed
Google Scholar
Singh N, Hussain S, Kakkar N, Singh SK, Sobti RC, Bharadwaj M. Implication of high risk Human papillomavirus HR-HPV infection in prostate cancer in Indian population- A pioneering case-control analysis. Sci Rep. 2015;5:7822.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang L, Wu MG, He J, Wei ZS, Lü WX, Song XJ, et al. Correlation of high-risk HPV 16/18 infections with prostate cancer. Zhonghua Nan Ke Xue. 2016;22:501–5 Chinese.
CAS
PubMed
Google Scholar
Dávila-Rodríguez MI, Ignacio Morales CV, Aragón Tovar AR, Olache Jimenez D, Castelán Maldonado E, Lara Miranda S, et al. Human papilloma virus detection by INNOLiPA HPV in prostate tissue from men of Northeast Mexico. Asian Pac J Cancer Prev. 2016;17:4863–5.
PubMed
Google Scholar
Atashafrooz F, Rokhbakhsh-Zamin F. Frequency and type distribution of human papilloma virus in patients with prostate Cancer, Kerman, southeast of Iran. Asian Pac J Cancer Prev. 2016;17:3953–8.
PubMed
Google Scholar
Medel-Flores O, Valenzuela-Rodríguez VA, Ocadiz-Delgado R, Castro-Muñoz LJ, Hernández-Leyva S, Lara-Hernández G, et al. Association between HPV infection and prostate cancer in a Mexican population. Genet Mol Biol. 2018;41:781–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD. Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate. 1993;22:171–80.
Article
CAS
PubMed
Google Scholar
Pascale M, Pracella D, Barbazza R, Marongiu B, Roggero E, Bonin S, et al. Is human papillomavirus associated with prostate cancer survival? Dis Markers. 2013;35:607–13.
Article
PubMed
PubMed Central
Google Scholar
Glenn WK, Ngan CC, Amos TG, Edwards RJ, Swift J, Lutze-Mann L, et al. High risk human papillomaviruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer. Infect Agent Cancer. 2017;12:46.
Article
PubMed
PubMed Central
CAS
Google Scholar
Masood S, Rhatigan RM, Powell S, Thompson J, Rodenroth N. Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J. 1991;84:235–6.
Article
CAS
PubMed
Google Scholar
Effert PJ, Frye RA, Neubauer A, Liu ET, Walther PJ. Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. J Urol. 1992;147:192–6.
Article
CAS
PubMed
Google Scholar
Serfling U, Ciancio G, Zhu WY, Leonardi C, Penneys NS. Human papillomavirus and herpes virus DNA are not detected in benign and malignant prostatic tissue using the polymerase chain reaction. J Urol. 1992;148:192–4.
Article
CAS
PubMed
Google Scholar
Anderson M, Handley J, Hopwood L, Murant S, Stower M, Maitland NJ. Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing. J Med Virol. 1997;52:8–13.
Article
CAS
PubMed
Google Scholar
Noda T, Sasagawa T, Dong Y, Fuse H, Namiki M, Inoue M. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res. 1998;126:165–9.
Article
Google Scholar
Saad F, Gu K, Jean-Baptiste J, Gauthier J, MesMasson AM. Absence of human papillomavirus sequences in early stage prostate cancer. Can J Urol. 1999;6:834–8.
PubMed
Google Scholar
Gazzaz FS, Mosli HA. Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J. 2009;30:633–7.
PubMed
Google Scholar
Yow MA, Tabrizi SN, Severi G, Bolton DM, Pedersen J, Longano A, et al. Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer. 2014;14:579.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lenze D, Müller H, Hummel M. Considerations for the use of formalin-fixed and paraffin-embedded tissue specimens for clonality analysis. Journal of Hematopathology. 2012;5:27–34.
Article
Google Scholar
Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E. The landscape of viral 464 expression and host gene fusion and adaptation in human cancer. Nat Commun. 2013;4:2513.
Article
PubMed
CAS
Google Scholar
Vinner L, Mourier T, Friis-Nielsen J, Gniadecki R, Dybkaer K, Rosenberg J, et al. Investigation of human cancers for retrovirus by low-stringency target enrichment and high-throughput sequencing. Sci Rep. 2015;5:13201.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dillner J, Knekt P, Boman J, Lehtinen M, Af Geijersstam V, Sapp M, et al. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer. 1998;75:564–7.
Article
CAS
PubMed
Google Scholar
Hisada M, Rabkin CS, Strickler HD, Wright WE, Christianson RE, van den Berg BJ. Human papillomavirus antibody and risk of prostate cancer. JAMA. 2000;283:340–1.
Article
CAS
PubMed
Google Scholar
Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM, et al. Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer. 2000;82:718–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomark Prev. 2003;12:763–8.
Google Scholar
Adami HO, Kuper H, Andersson SO, Bergström R, Dillner J. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomark Prev. 2003;12:872–5.
Google Scholar
Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, et al. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomark Prev. 2005;14:2952–5.
Article
CAS
Google Scholar
Sutcliffe S, Giovannucci E, Gaydos CA, Viscidi RP, Jenkins FJ, Zenilman JM, et al. Plasma antibodies against chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomark Prev. 2007;16:1573–80.
Article
CAS
Google Scholar
Sitas F, Urban M, Stein L, Beral V, Ruff P, Hale M, et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black south African population. Infect Agent Cancer. 2007;2:6.
Article
PubMed
PubMed Central
CAS
Google Scholar
Huang WY, Hayes R, Pfeiffer R, Viscidi RP, Lee FK, Wang YF, et al. Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomark Prev. 2008;17:2374–81.
Article
CAS
Google Scholar
Dennis LK, Coughlin JA, McKinnon BC, Wells TS, Gaydos CA, Hamsikova E, et al. Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomark Prev. 2009;18:2665–71.
Article
Google Scholar
Sutcliffe S, Viscidi RP, Till C, Goodman PJ, Hoque AM, Hsing AW, et al. Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the prostate Cancer prevention trial. Cancer Epidemiol Biomark Prev. 2010;19:614–8.
Article
CAS
Google Scholar
Hrbacek J, Urban M, Hamsikova E, Tachezy R, Eis V, Brabec M, Heracek J. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer. 2011;11:53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao X, Zhou Z, Chen Y, Chen W, Ma H, Pu J. Role of antibodies to human papillomavirus 16 in prostate cancer: a seroscreening by peptide microarray. Tumour Biol. 2017;39:1–9.
Google Scholar
Combes JD, Pawlita M, Waterboer T, Hammouda D, Rajkumar T, Vanhems P, et al. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer. 2014;135:2453–61.
Article
CAS
PubMed
Google Scholar
Taylor ML, Mainous AG 3rd, Wells BJ. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med. 2005;37:506–12.
PubMed
Google Scholar
Johnson AM, Mercer CH, Beddows S, de Silva N, Desai S, Howell-Jones R, et al. Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain. Sex Transm Infect. 2012;88:212–7.
Article
PubMed
Google Scholar
Lyu Z, Feng X, Li N, Zhao W, Wei L, Chen Y, et al. Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis. BMC Infect Dis. 2017;17:714.
Article
PubMed
PubMed Central
Google Scholar
Guenat D, Hermetet F, Prétet J-L, Mougin C. Exosomes and other extracellular vesicles in HPV transmission and carcinogenesis. Viruses. 2017;9:211.
Article
PubMed Central
CAS
Google Scholar
De Carolis S, Storci G, Ceccarelli C, Savini C, Gallucci L, Sansone P, et al. HPV DNA associates with breast Cancer malignancy and it is transferred to breast Cancer stromal cells by extracellular vesicles. Front Oncol. 2019;9:860.
Article
PubMed
PubMed Central
Google Scholar
Gupta I, Nasrallah GK, Sharma A, Jabeen A, Smatti MK, Al-Thawadi HA, Sultan AA, Alkhalaf M. Vranic, Al Moustafa A-E. co-prevalence of human papillomaviruses (HPV) and Epstein–Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar. Cancer Cell Int. 2020;20:107.
Article
PubMed
PubMed Central
Google Scholar
Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS, et al. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci U S A. 1994;91:11874–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Naghashfar Z, DiPaolo JA, Woodworth CD, Passaniti A. Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and −18 DNA. Cancer Lett. 1996;100:47–54.
Article
CAS
PubMed
Google Scholar
Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis. 1997;18:1215–23.
Article
CAS
PubMed
Google Scholar
Sitas F, Urban M, Stein L, Beral V, Ruff P, Hale M, et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate. 1999;40:150–8.
Article
Google Scholar
Schütze DM, Snijders PJ, Bosch L, Kramer D, Meijer CJ, Steenbergen RD. Differential in vitro immortalization capacity of eleven (probable) high-risk human papillomavirus types. J Virol. 2014;88:1714–24.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chang JL, Tsao YP, Liu DW, Huang SJ, Lee WH, Chen SL. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci. 2001;8:206–13.
Article
CAS
PubMed
Google Scholar
Krawczyk E, Suprynowicz FA, Liu X, Dai Y, Hartmann DP, Hanover J, et al. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol. 2008;173:682–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grulich AE, Vajdic CM. The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol. 2015;42:247–57.
Article
PubMed
Google Scholar
Ohba K, Ichiyama K, Yajima M, Gemma N, Nikaido M. Wu Q, et al in vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction. PLoS One. 2014;9:e97787.
Article
PubMed
PubMed Central
CAS
Google Scholar
Vieira VC, Leonard B, White EA, Starrett GJ, Temiz NA, Lorenz LD, et al. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B. MBio. 2014;5:e02234–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gansmo LB, Romundstad P, Hveem K, Vatten L, Nik-Zainal S, Lønning PE, et al. APOBEC3A/B deletion polymorphism and cancer risk. Carcinogenesis. 2018;39:118–24.
Article
CAS
PubMed
Google Scholar
Cheng AZ, Yockteng-Melgar J, Jarvis MC, Malik-Soni N, Borozan I, Carpenter MA, McCann JL, Ebrahimi D, Shaban NM, Marcon E, Greenblatt J, Brown WL, Frappier L, Harris RS. Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity. Nat Microbiol. 2019;4:78–88.
Article
CAS
PubMed
Google Scholar
Shi Y, Peng SL, Yang LF, Chen X, Tao YG, Cao Y. Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chin J Cancer. 2016;35:16.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gao G, Smith DI. Human papillomavirus and the development of different cancers. Cytogenet Genome Res. 2016;150:185–93.
Article
PubMed
CAS
Google Scholar
Hagensee ME, Herrel N, D’Angelo A, Sutton K, Clark R, Cameron JE. Epstein Barr virus interacts with human papillomavirus to decrease apoptosis in-vitro and increase cervical dysplasia in vivo. Trieste: International Centre for Genetic Engineering and Biotechnology. DNA tumour virus meeting; 2011. p. 157.
Google Scholar
Zhang L, Wang Y, Qin Z, Gao X, Xing Q, Li R, et al. Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis. J Cancer. 2020;11:177–89.
Article
PubMed
PubMed Central
Google Scholar
Xiao J, Ren L, Lv H, Ding Q, Lou S, Zhang W, et al. Atypical microorganisms in expressed prostatic secretion from patients with chronic prostatitis/chronic pelvic pain syndrome: microbiological results from a case-control study. Urol Int. 2013;91:410–6.
Article
CAS
PubMed
Google Scholar
Bartoletti R, Cai T, Meliani E, Mondaini N, Meacci F, Addonisio P, et al. Human papillomavirus infection is not related with prostatitis-related symptoms: results from a case-control study. Int Braz J Urol. 2014;40:247–56.
Article
PubMed
Google Scholar
La Vignera S, Condorelli RA, Cannarella R, Giacone F, Mongioi’ L, Scalia G, et al. High rate of detection of ultrasound signs of prostatitis in patients with HPV-DNA persistence on semen: role of ultrasound in HPV-related male accessory gland infection. J Endocrinol Invest. 2019;42:1459–65.
Article
PubMed
CAS
Google Scholar
Jain P, Ghosh A, Jana D, Pal DK. Chronic pelvic pain syndrome/chronic prostatitis: is it related to human papillomavirus infection? A case-control study from eastern India. Urologia. 2020;2020:391560319899848. https://doi.org/10.1177/0391560319899848 [Epub ahead of print].
Article
Google Scholar
Harper DM, DeMars LR. HPV vaccines - a review of the first decade. Gynecol Oncol. 2017;146:196–204.
Article
CAS
PubMed
Google Scholar